Table 2 Univariate and multivariate analysis of clinical characteristics and laboratory data of in LC patients

Age

0.004

2.168

1.266–3.713

0.018*

1.966

1.123–3.440

Gender

0.173

1.485

0.839–2.629

Smoking

0.258

1.337

0.807–2.213

Metastasis

 Liver

0.002

3.278

1.501–7.161

0.011*

2.911

1.277–6.636

 Lymphnodes

0.471

1.193

0.738–1.926

 Kidney

0.356

0.519

0.125–2.146

 Brain

0.172

0.645

0.342–1.216

 Bone

0.505

1.199

0.703–2.042

 Staging

0.754

1.044

0.799–1.363

 Classification

0.680

1.080

0.749–1.556

 α-HBDH (U/L)

0.023

1.774

1.075–2.926

0.015*

1.892

1.129–3.170

 LDH (U/L)

0.068

1.559

0.964–2.521

0.895

 HCY (umol/L)

0.299

1.288

0.798–2.080

 FIB g/L

0.075

1.551

0.954–2.522

0.151

 CEA ng/ml

0.062

0.250

0.058–1.072

0.933

 AFP IU/ml

0.170

0.655

0.356–1.204

 TP g/L

0.227

0.687

0.372–1.268

 ALB g/L

0.021

0.556

0.336–0.922

0.566

 A/G

0.368

0.780

0.453–1.342

 Ca mmol/L

0.671

0.832

0.355–1.947

 WBC × 10⁹/L

0.013

1.896

1.144–3.145

0.153

 NLR

0.009

1.965

1.174–3.290

0.031*

1.787

1.054–3.029

 PLT × 10⁹/L

0.629

0.894

0.567–1.409